About NatiMab Therapeutics

About company

NatiMab Therapeutics identifies and develops human antibodies (Abs) for the therapy and diagnosis of infectious diseases and cancer. NatiMab Therapeutics is an Italian SME located in the premises of the Bioindustry Park Canavese scientific and technological park, at Colleretto Giacosa (Torino). Registered on 02/01/2008 in Torino, NatiMab was founded by Gianni Garotta, Maurizio Denaro, Marianne Murphy and Gerritt Hagens. On 10/12/2014, two previously key collaborators, Francesco Novelli and Guido Forni joined the company as shareholders.